Tag: Employer Solutions

News

2014 SAPAA conference

September 17, 2014

As a platinum sponsor of the SAPAA conference, we couldn't be more excited about this gathering of thought leaders and experts from the industry.

Oral Fluid testing

Ask the experts: Under the influence

September 8, 2014

Is oral fluid is the best drug test specimen type for determining whether an employee is under the influence of drugs – particularly marijuana?

Synthetic drugs

National Drug Early Warning System

August 26, 2014

This new system will monitor emerging drug trends that will help health experts identify increasing use of designer synthetic compounds.

Drugs & Alcohol

Prescription opioids: A dose of reality

July 29, 2014

Prescription drug abuse is the nation's fastest-growing drug problem and has been classified as an epidemic by the CDC.

News

New Quest study examines prescription drug misuse

July 21, 2014

A new Quest Diagnostics Health Trends™ report examines the risks of prescription drug misuse and efforts at the state level to reduce abuse.

Collections

Drug testing collection site network

July 15, 2014

Not all collection sites are created equal, and it’s important to know the differences between each type of site when making a location selection.

Collections

Revised urine specimen collector guidelines

July 3, 2014

ODAPC issued an official Q&A document that clarifies collector guidelines outlined in 49 CFR Part 40.

Online Solutions

Suite of online solutions: FormFox

July 1, 2014

FormFox simplifies the collection process for non-regulated urine, oral fluid, hair, and instant drug testing and mirrors drug testing protocol.

Marijuana

Marijuana webinar recap

June 27, 2014

Experts presented a webinar about marijuana use, common terminology, state laws, and insights from the Quest Diagnostics Drug Testing Index.

Oral Fluid testing

Ask the experts: Oral fluid collections

June 26, 2014

The vast majority of Oral-Eze collections are simple, fast, and provide specimens that can be tested without any issues.